Table 4.
Details of those variants most likely to have a functional effect based on the bioinformatics analyses performed.
| Site Disrupted/Created | ||||
|---|---|---|---|---|
| Variant | ESE Abolished | Novel Acceptor Site Created | ||
| Start position | Sequencea | End position | ||
| rs1164957 | 2 SF2/ASF motifs | |||
| rs1494550 (SNP 5) | 24160423 | AG | 24160424 | |
| n20 (SNP 6) | 24174105 | CT | 24174106 | |
| rs2021512 | 24174976 | AGTTT | 24174980 | |
The position of the indicated variant is shown in bold. This is not shown for SNP6 because the nucleotide is deleted. The splice-site dinucleotide is underlined.